JPMA Think Tank Finds Surge in Japan-Unapproved Drugs in Areas with High Unmet Needs

July 12, 2022
The think tank arm of the Japan Pharmaceutical Manufacturers Association (JPMA) on July 8 issued reports indicating Japan’s increasing drug lag in the areas of high unmet medical needs, pointing out the impediments hampering biotech firms from developing innovative new...read more